144 research outputs found
Human Nail Plate Modifications Induced by Onychomycosis : Implications for Topical Therapy
Open Access - This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are creditedConclusions: Onchomycotic nails presented a thicker but more porous barrier, and its eroded intracellular matrix rendered the tissue more permeable to topically applied chemicals when an aqueous vehicle was used.Purpose: Through the characterisation of the human onchomycotic nail plate this study aimed to inform the design of new topical ungual formulations.Methods: The mechanical properties of the human nail were characterised using a Lloyd tensile strength tester. The nailâs density was determined via pycnometry and the nailâs ultrastructure by electron microscopy. Raman spectroscopy analysed the keratin disulphide bonds within the nail and its permeability properties were assessed by quantifying water and rhodamine uptake.Results: Chronic in vivo nail plate infection increased human nailplate thickness (healthy 0.49 ± 0.15 mm; diseased 1.20 ± 0.67 mm), but reduced its tensile strength (healthy 63.7 ± 13.4 MPa; diseased 41.7 ± 5.0 MPa) and density (healthy 1.34 ± 0.01 g/cm3; diseased 1.29 ± 0.00 g/cm3). Onchomycosis caused cell-cell separation, without disrupting the nail disulfide bonds or desmosomes. The diseased and healthy nails showed equivalent water uptake profiles, but the rhodamine penetration was 4-fold higher in the diseased nails using a PBS vehicle and 3 -fold higher in an ethanol/PBS vehicle.Peer reviewe
Onicomicose: estudo clĂnico, epidemiolĂłgico e micolĂłgico no municĂpio de SĂŁo JosĂ© do Rio Preto
Novel Sulfated Polysaccharides Disrupt Cathelicidins, Inhibit RAGE and Reduce Cutaneous Inflammation in a Mouse Model of Rosacea
Rosacea is a common disfiguring skin disease of primarily Caucasians characterized by central erythema of the face, with telangiectatic blood vessels, papules and pustules, and can produce skin thickening, especially on the nose of men, creating rhinophyma. Rosacea can also produce dry, itchy eyes with irritation of the lids, keratitis and corneal scarring. The cause of rosacea has been proposed as over-production of the cationic cathelicidin peptide LL-37.We tested a new class of non-anticoagulant sulfated anionic polysaccharides, semi-synthetic glycosaminoglycan ethers (SAGEs) on key elements of the pathogenic pathway leading to rosacea. SAGEs were anti-inflammatory at ng/ml, including inhibition of polymorphonuclear leukocyte (PMN) proteases, P-selectin, and interaction of the receptor for advanced glycation end-products (RAGE) with four representative ligands. SAGEs bound LL-37 and inhibited interleukin-8 production induced by LL-37 in cultured human keratinocytes. When mixed with LL-37 before injection, SAGEs prevented the erythema and PMN infiltration produced by direct intradermal injection of LL-37 into mouse skin. Topical application of a 1% (w/w) SAGE emollient to overlying injected skin also reduced erythema and PMN infiltration from intradermal LL-37.Anionic polysaccharides, exemplified by SAGEs, offer potential as novel mechanism-based therapies for rosacea and by extension other LL-37-mediated and RAGE-ligand driven skin diseases
Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis
Background
Onychomycosis is a fungal infection of the nail caused by dermatophytes, yeasts and nonâdermatophyte moulds that accounts for approximately 50% of all nail related disease.
Objectives
This study aims to assess the effectiveness and safety of monotherapy and combination treatments for toenail onychomycosis using a network metaâanalysis (NMA).
Methods
Quality of evidence was assessed using Cochraneâcompliant rules and the Grading of Recommendations, Assessment, Development and Evaluations approach. Efficacy and safety outcomes were compared using a randomâeffects network metaâanalysis to estimate pooled odds ratios (ORs) of direct and indirect comparisons amongst oral and topical treatments (PROSPERO 2015: CRD42018086912). There were not enough eligible combination and deviceâbased therapy trials to include in the NMA.
Results
Of 77 randomised controlled trials, 26 were included in the network metaâanalysis (8,136 patients). There were no significant inconsistencies between the direct and indirect evidence. Relative effects show that odds of mycological cure with continuous terbinafine 250 mg or continuous itraconazole 200 mg are significantly greater than topical treatments. Fluconazole, pulse regimens of terbinafine and itraconazole, and topical treatments did not differ significantly in odds of achieving mycological cure. The odds ratios of adverse events occurring with oral or topical treatments were not significantly different from each other. For mycological cure, evidence was of moderate or high quality while evidence ranged from very low to high quality for adverse events.
Conclusions
Our review suggests that oral and topical treatments for toenail onychomycosis are safe and effective in producing mycological cure
- âŠ